KRAS is one of the most commonly mutated oncogenes in human cancers, accounting for 92% of pancreatic ductal adenocarcinomas, 49% of colorectal carcinomas, and 35% of lung adenocarcinomas (1–3). The gene discussed is KRAS; the disease is cancer.